MSM/13
Meeting of the Member State mechanism on substandard and falsified medical products
A/MSM/13
List of participants – Liste des Délégués
A/MSM/13/1
Provisional agenda
A/MSM/13/2
Update by the Secretariat on the activities and budget to implement the workplan of the Member State mechanism
A/MSM/13/3
Updates on the prioritized activities for 2024–2025, including the strategic plan
A/MSM/13/4
Updates on the prioritized activities for 2024–2025, including the strategic plan
Strengthen the capacity of national/regional regulatory authorities for the prevention and detection of, and response to, substandard and falsified medical products
Executive summary linked to Activity A
A/MSM/13/5
Updates on the prioritized activities for 2024–2025, including the strategic plan
Improve Member States’ understanding and uptake of technologies to screen and detect substandard and falsified medical products
Executive summary linked to Activity C
A/MSM/13/6
Updates on the prioritized activities for 2024–2025, including the strategic plan
Improve Member States’ implementation of national traceability systems
Executive summary linked to Activity J
A/MSM/13/7
Report on the evaluation of the Member State mechanism
A/MSM/13/8
Report of the thirteenth meeting of the Member State mechanism on substandard and falsified medical products
